SCHEMBL30810271

SCHEMBL30810271

COC(=O)c1cc(Cl)cc(C(=O)O)c1OC

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.53
ALDH1A1 P00352 3/20 0.51
HPGD P15428 2/20 0.51
NPSR1 Q6W5P4 1/20 0.51
HSD17B10 Q99714 1/20 0.46
ACLY P53396 3/20 0.45
ABL1 P00519 1/20 0.45
APEX1 P27695 1/20 0.45
SERPINH1 P50454 1/20 0.44
POLB P06746 1/20 0.44
AKR1C4 P17516 1/20 0.43
AKR1C3 P42330 1/20 0.43
AKR1C2 P52895 1/20 0.43
AKR1C1 Q04828 1/20 0.43
GAA P10253 1/20 0.42
SLC6A4 P31645 1/20 0.42
SLC6A3 Q01959 1/20 0.42
CYP3A4 P08684 1/20 0.42
MEN1 O00255 1/20 0.41
LMNA P02545 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30239427 0.91 KDM4E (0.60) KDM4EALDH1A1HPGDHSD17B10ACLY
SCHEMBL18393285 0.84 GALK1 (0.51) KDM4EALDH1A1HPGDNPSR1HSD17B10
SCHEMBL11179872 0.82 KDM4E (0.56) KDM4EALDH1A1HPGDNPSR1HSD17B10
SCHEMBL30810259 0.82 ALDH1A1 (0.47) KDM4EALDH1A1HPGDNPSR1HSD17B10
SCHEMBL19612124 0.82 ALDH1A1 (0.47) KDM4EALDH1A1HPGDNPSR1HSD17B10
SCHEMBL30084374 0.81 ACLY (0.56) KDM4EALDH1A1HPGDHSD17B10ACLY
SCHEMBL423692 0.81 ACLY (0.56) KDM4EALDH1A1HPGDHSD17B10ACLY
SCHEMBL10994738 0.81 KDM4E (0.44) KDM4EALDH1A1HPGDNPSR1ACLY
SCHEMBL4129252 0.81 HSD17B10 (0.49) KDM4EALDH1A1HPGDNPSR1HSD17B10
SCHEMBL13280732 0.81 ABL1 (0.60) KDM4EALDH1A1HPGDNPSR1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4583870-A2 MITOCHONDRIAL UNCOUPLERS FOR TREATMENT OF METABOLIC DISEASES AND CANCER Mito Biopharma, LLC (US) 2025-07-16 EP disclosed
WO-2024054766-A2 MITOCHONDRIAL UNCOUPLERS FOR TREATMENT OF METABOLIC DISEASES AND CANCER MITO BIOPHARMA, LLC (US) 2024-03-14 WO disclosed